Nalaganje...
Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes
BACKGROUND: Neutralising antibodies to sclerostin (Scl-Ab) have shown significant potential to induce bone formation and decrease bone resorption, increase strength and substantially reduce fracture risk in animal studies and clinical trials. Mechanical loading negatively regulates sclerostin expres...
Shranjeno v:
| izdano v: | BMC Mol Cell Biol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7643443/ https://ncbi.nlm.nih.gov/pubmed/33148174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12860-020-00322-w |
| Oznake: |
Označite
Brez oznak, prvi označite!
|